BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 37290426)

  • 1. A systematic review and meta-analysis of randomized controlled trials to evaluate plant-based omega-3 polyunsaturated fatty acids in nonalcoholic fatty liver disease patient biomarkers and parameters.
    Moore E; Patanwala I; Jafari A; Davies IG; Kirwan RP; Newson L; Mazidi M; Lane KE
    Nutr Rev; 2024 Jan; 82(2):143-165. PubMed ID: 37290426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 polyunsaturated fatty acid supplementation and non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
    Yan JH; Guan BJ; Gao HY; Peng XE
    Medicine (Baltimore); 2018 Sep; 97(37):e12271. PubMed ID: 30212963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of omega-3 fatty acids on liver-related outcomes in patients with nonalcoholic fatty liver disease: A protocol for a systematic review and meta-analysis.
    Shi XY; Fan SM; Shi GM; Yao J; Gao Y; Xia YG; Chen Q
    Medicine (Baltimore); 2020 Jun; 99(24):e20624. PubMed ID: 32541499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Omega-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials.
    He XX; Wu XL; Chen RP; Chen C; Liu XG; Wu BJ; Huang ZM
    PLoS One; 2016; 11(10):e0162368. PubMed ID: 27711128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omega-3 polyunsaturated fatty acids in the treatment of non-alcoholic fatty liver disease: An umbrella systematic review and meta-analysis.
    Musazadeh V; Karimi A; Malekahmadi M; Ahrabi SS; Dehghan P
    Clin Exp Pharmacol Physiol; 2023 May; 50(5):327-334. PubMed ID: 36692292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials.
    Guo XF; Yang B; Tang J; Li D
    Clin Nutr; 2018 Feb; 37(1):113-122. PubMed ID: 28161092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omega-3 fatty acids as a treatment for non-alcoholic fatty liver disease in children: A systematic review and meta-analysis of randomized controlled trials.
    Chen LH; Wang YF; Xu QH; Chen SS
    Clin Nutr; 2018 Apr; 37(2):516-521. PubMed ID: 28040302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of curcumin supplementation on body mass index, body weight, and waist circumference in patients with nonalcoholic fatty liver disease: A systematic review and dose-response meta-analysis of randomized controlled trials.
    Baziar N; Parohan M
    Phytother Res; 2020 Mar; 34(3):464-474. PubMed ID: 31799714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review and meta-analysis of controlled intervention studies on the effectiveness of long-chain omega-3 fatty acids in patients with nonalcoholic fatty liver disease.
    Musa-Veloso K; Venditti C; Lee HY; Darch M; Floyd S; West S; Simon R
    Nutr Rev; 2018 Aug; 76(8):581-602. PubMed ID: 29917092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness and acceptability of Mediterranean diet and calorie restriction in non-alcoholic fatty liver disease (NAFLD): A systematic review and meta-analysis.
    Haigh L; Kirk C; El Gendy K; Gallacher J; Errington L; Mathers JC; Anstee QM
    Clin Nutr; 2022 Sep; 41(9):1913-1931. PubMed ID: 35947894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of dietary polyphenol supplementation in the treatment of non-alcoholic fatty liver disease: A systematic review and meta-analysis.
    Yang K; Chen J; Zhang T; Yuan X; Ge A; Wang S; Xu H; Zeng L; Ge J
    Front Immunol; 2022; 13():949746. PubMed ID: 36159792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 Fatty acids therapy in children with nonalcoholic Fatty liver disease: a randomized controlled trial.
    Janczyk W; Lebensztejn D; Wierzbicka-Rucińska A; Mazur A; Neuhoff-Murawska J; Matusik P; Socha P
    J Pediatr; 2015 Jun; 166(6):1358-63.e1-3. PubMed ID: 25771388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effects of Olive Oil Consumption on Biochemical Parameters and Body Mass Index of People with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Tsamos G; Kalopitas G; Evripidou K; Vasdeki D; Koufakis T; Kanavas V; Antza C; Germanidis G; Chourdakis M
    Nutrients; 2024 Mar; 16(6):. PubMed ID: 38542768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome-targeted therapies in nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression.
    Sharpton SR; Maraj B; Harding-Theobald E; Vittinghoff E; Terrault NA
    Am J Clin Nutr; 2019 Jul; 110(1):139-149. PubMed ID: 31124558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of carnitine supplementation on clinical characteristics of patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials.
    Abolfathi M; Mohd-Yusof BN; Hanipah ZN; Mohd Redzwan S; Yusof LM; Khosroshahi MZ
    Complement Ther Med; 2020 Jan; 48():102273. PubMed ID: 31987257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does turmeric/curcumin supplementation improve serum alanine aminotransferase and aspartate aminotransferase levels in patients with nonalcoholic fatty liver disease? A systematic review and meta-analysis of randomized controlled trials.
    Goodarzi R; Sabzian K; Shishehbor F; Mansoori A
    Phytother Res; 2019 Mar; 33(3):561-570. PubMed ID: 30653773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin supplementation effect on liver enzymes in patients with nonalcoholic fatty liver disease: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
    Vajdi M; Hassanizadeh S; Hassanizadeh R; Bagherniya M
    Nutr Rev; 2024 Jan; ():. PubMed ID: 38213188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of synbiotic supplementation in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of clinical trials: Synbiotic supplementation and NAFLD.
    Hadi A; Mohammadi H; Miraghajani M; Ghaedi E
    Crit Rev Food Sci Nutr; 2019; 59(15):2494-2505. PubMed ID: 29584449
    [No Abstract]   [Full Text] [Related]  

  • 20. The Effectiveness of eHealth Interventions on Lifestyle Modification in Patients With Nonalcoholic Fatty Liver Disease: Systematic Review and Meta-analysis.
    Kwon OY; Choi JY; Jang Y
    J Med Internet Res; 2023 Jan; 25():e37487. PubMed ID: 36689264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.